Total Payments
$49,928
2024 Payments
$192.08
Companies
31
Transactions
277
Medicare Patients
534
Medicare Billing
$61,493
Payment Breakdown by Category
Other$36,425 (73.0%)
Travel$6,696 (13.4%)
Food & Beverage$6,602 (13.2%)
Education$205.36 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,425 | 17 | 73.0% |
| Travel and Lodging | $6,696 | 36 | 13.4% |
| Food and Beverage | $6,602 | 222 | 13.2% |
| Education | $205.36 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $22,109 | 42 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $17,687 | 70 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $4,346 | 20 | $0 (2019) |
| Medtronic MiniMed, Inc. | $2,096 | 22 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,000 | 17 | $0 (2022) |
| Novo Nordisk Inc | $479.43 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $400.72 | 16 | $0 (2020) |
| Abbott Laboratories | $336.68 | 11 | $0 (2021) |
| Insulet Corporation | $191.77 | 4 | $0 (2022) |
| AbbVie, Inc. | $152.94 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192.08 | 3 | Novo Nordisk Inc ($116.82) |
| 2023 | $107.57 | 2 | Amarin Pharma Inc. ($86.64) |
| 2022 | $261.11 | 3 | Insulet Corporation ($134.47) |
| 2021 | $483.42 | 7 | Abbott Laboratories ($212.11) |
| 2020 | $307.58 | 16 | AstraZeneca Pharmaceuticals LP ($73.78) |
| 2019 | $8,695 | 62 | Merck Sharp & Dohme Corporation ($5,288) |
| 2018 | $22,524 | 91 | Merck Sharp & Dohme Corporation ($16,521) |
| 2017 | $17,357 | 93 | Janssen Pharmaceuticals, Inc ($10,332) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $60.67 | General |
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $75.26 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $56.15 | General |
| 02/08/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $86.64 | General |
| Category: Cardiovascular | ||||||
| 01/05/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $113.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/12/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $134.47 | General |
| Category: Insulin Pump | ||||||
| 01/18/2022 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Endocrinology | ||||||
| 12/21/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Diabetes Care | ||||||
| 09/30/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.10 | General |
| 09/21/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2021 | Abbott Laboratories | FreeStyle Lite system (Device) | Education | In-kind items and services | $199.96 | General |
| Category: Diabetes Care | ||||||
| 09/09/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $117.38 | General |
| Category: Cardio-renal | ||||||
| 09/03/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: Diabetes Care | ||||||
| 01/12/2021 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Endocrinology | ||||||
| 09/24/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes Care | ||||||
| 08/18/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/17/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Diabetes | ||||||
| 08/03/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Bone Health | ||||||
| 07/14/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: DIABETES | ||||||
| 03/16/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes Care | ||||||
| 03/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: DIABETES | ||||||
| 02/27/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $61.37 | General |
| 02/13/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: DIABETES | ||||||
| 02/12/2020 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 27 | 28 | $7,028 | $1,041 |
| 2022 | 5 | 226 | 332 | $89,896 | $30,260 |
| 2021 | 3 | 83 | 87 | $29,823 | $10,704 |
| 2020 | 9 | 198 | 323 | $56,222 | $19,487 |
Total Patients
534
Total Services
770
Medicare Billing
$61,493
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 28 | $7,028 | $1,041 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 165 | $41,415 | $15,277 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $26,044 | $7,462 | 28.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $14,460 | $4,944 | 34.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 23 | 49 | $4,557 | $1,320 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 20 | $3,420 | $1,257 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 43 | $10,793 | $4,411 | 40.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $10,604 | $3,591 | 33.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $8,426 | $2,703 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 129 | $23,865 | $7,486 | 31.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 42 | 59 | $8,374 | $3,203 | 38.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 28 | $7,448 | $2,348 | 31.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 16 | $5,616 | $1,759 | 31.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 15 | 15 | $3,990 | $1,447 | 36.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 18 | 19 | $1,900 | $1,205 | 63.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 16 | 24 | $2,424 | $755.28 | 31.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 18 | 18 | $1,210 | $741.81 | 61.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 15 | 15 | $1,395 | $541.20 | 38.8% |
About Sathya Jyothinagaram, M.D.,
Sathya Jyothinagaram, M.D., is a Endocrinology, Diabetes & Metabolism healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538192703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sathya Jyothinagaram, M.D., has received a total of $49,928 in payments from pharmaceutical and medical device companies, with $192.08 received in 2024. These payments were reported across 277 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,425).
As a Medicare-enrolled provider, Jyothinagaram has provided services to 534 Medicare beneficiaries, totaling 770 services with total Medicare billing of $61,493. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Phoenix, AZ
- Active Since 07/09/2006
- Last Updated 06/25/2014
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1538192703
Products in Payments
- STEGLATRO (Drug) $21,670
- INVOKANA (Drug) $17,669
- SOLIQUA (Drug) $4,057
- Minimed 670G System (Device) $1,984
- FARXIGA (Drug) $569.22
- JARDIANCE (Drug) $427.18
- JANUVIA (Drug) $341.86
- FreeStyle Lite system (Device) $199.96
- Omnipod (Device) $191.77
- TOUJEO (Drug) $164.68
- XIGDUO (Drug) $151.52
- t-slim insulin pump (Device) $138.14
- Victoza (Drug) $120.81
- Kerendia (Drug) $117.38
- Minimed 530G (Device) $112.42
- Ozempic (Drug) $107.27
- Korlym (Drug) $88.23
- Vascepa (Drug) $86.64
- DEXCOM CGM (Device) $84.71
- Synthroid (Drug) $82.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Phoenix
Joan Bailey, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $521,210
Endocrinology, Diabetes & Metabolism $521,210
Dr. Kevin Yuen, Mbchb, Md, Frcp(Uk), MBCHB, MD, FRCP(UK)
Endocrinology, Diabetes & Metabolism — Payments: $440,499
Endocrinology, Diabetes & Metabolism $440,499
Kari Brown, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $35,348
Endocrinology, Diabetes & Metabolism $35,348
Dr. Anna Boron, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $32,760
Endocrinology, Diabetes & Metabolism $32,760
Lory Baraz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $11,847
Endocrinology, Diabetes & Metabolism $11,847
Dr. Peter Reaven, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $11,066
Endocrinology, Diabetes & Metabolism $11,066